# Multiple Dose Pharmacokinetics of Intranasal Ketamine

> **NCT00519987** · PHASE1 · COMPLETED · sponsor: **Javelin Pharmaceuticals** · enrollment: 18 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** intranasal ketamine

## Key facts

- **NCT ID:** NCT00519987
- **Lead sponsor:** Javelin Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** 2007-08
- **Final completion:** 2007-08
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2008-01-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00519987

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00519987, "Multiple Dose Pharmacokinetics of Intranasal Ketamine". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00519987. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*